This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: Florence Cabon-Georget: Innovator in Cancer Treatment
Introduction
Florence Cabon-Georget is a notable inventor based in Vitry sur Seine, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing targeted therapies that aim to combat cancer at the molecular level.
Latest Patents
One of her latest patents is centered around a SiRNA-based cancer treatment. This invention involves a double-strand oligonucleotide that includes two complementary oligonucleotide sequences forming a hybrid. Each sequence contains one to five unpaired nucleotides at either the 3' or 5' ends, extending beyond the hybrid. This oligonucleotide sequence is designed to be substantially complementary to a target sequence belonging to a DNA or RNA molecule that is specifically repressed, particularly targeting genes coding for angiogenic factors.
Another significant patent by Cabon-Georget describes inhibitor oligonucleotides and their use for the specific repression of harmful genes. The method outlined in this patent involves administering a therapeutically effective amount of a pharmaceutical composition containing at least one double-stranded oligonucleotide. This oligonucleotide includes two complementary sequences forming a hybrid, with one sequence being substantially complementary to a target sequence belonging to a DNA or messenger RNA molecule of a gene coding for a mutated or nonmutated androgen receptor.
Career Highlights
Florence Cabon-Georget is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. Her work has been instrumental in advancing the understanding of gene therapy and its applications in treating cancer.
Collaborations
Throughout her career, Cabon-Georget has collaborated with esteemed colleagues, including Annick Harel-Bellan and Slimane Ait-Si-Ali. These collaborations have further enriched her research and contributed to the development of innovative cancer treatments.
Conclusion
Florence Cabon-Georget's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the field. Her work continues to pave the way for new therapeutic strategies that may significantly impact cancer care in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
